Seeking Alpha

More on Cepheid's (CPHD) Q4: Cites strong demand for its GeneXpert systems, despite tight...

More on Cepheid's (CPHD) Q4: Cites strong demand for its GeneXpert systems, despite tight capital in U.S. and Europe. Sets 2012 revenue guidance at $333M-$347M. Sees EPS falling in a range of $0.55 to $0.60. Shares +19.4% AH. (PR)

Check out Seeking Alpha’s new Earnings Center »

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs